Aethlon Medical, Inc. - "A Publication Describing the First Treatment of Ebola with the Aethlon Hemopurifier(R)"
New York, NY / ACCESSWIRE / February 12, 2015 / Aethlon Medical, Inc. (AEMD) today published a new blog post on The Chairman's Blog, written by the Company's Chairman and CEO, James Joyce. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.
In today's blog, Mr. Joyce expands on the manuscript entitled "Extracorporeal Virus Elimination for the Treatment of Severe Ebola Virus Disease - First Experience with Lectin Affinity Plasmapheresis", which was published February 11th, 2015 in the journal "Blood Purification". The journal details the first administration of Hemopurifier(R) therapy to an Ebola patient in Frankfurt, Germany. Read the full blog post from Mr. Joyce on TheChairmansBlog.com. (http://www.thechairmansblog.com/aethlon-medical/james-joyce/publication-describing-first-treatment-ebola-aethlon-hemopurifier/.)
About Aethlon Medical, Inc.
Aethlon Medical creates targeted therapeutic devices to address infectious disease, cancer and neurodegenerative disorders. The company's lead product is the Aethlon Hemopurifier(R), a first-in-class device that selectively targets the rapid elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. Exosome Sciences, Inc. is a majority owned subsidiary that is advancing exosome-based products to diagnose and monitor cancer, infectious disease and neurological disorders. For more information, please visit http://www.aethlonmedical.com/ and connect with the Company on Twitter, LinkedIn, Facebook and Google+.
About TheChairmansBlog.com
TheChairmansBlog.com is an exclusive, online media publication where publicly and privately held firms alike share insights about their companies and industries. TheChairmansBlog.com enables upper tier management to discuss issues that are of importance to their stakeholders, shareholders, and interested parties in an informal environment. www.thechairmansblog.com.
SOURCE: TheChairmansBlog.com
